NeoGenomics Inc.
NeoGenomics Inc. (NEO): 1 pipeline candidate · ~79 mo cash runway. Updated within the last hour.
BioSniper Score
5-factor signal · derived from public data
79.0 months
D/E 0.62 · 0% dilution
Lead: Approved
1 candidate
N/A
0 buys · 1 sell (180d)
A transparent, data-derived signal for NeoGenomics Inc.across cash runway, pipeline maturity & breadth, catalyst momentum and clinical/regulatory footprint. Each factor traces to tracked public filings — not an investment recommendation.
Key Financials
Market Cap
$1.4B
Cash
$146.1M
Quarterly Burn
$8.1M
Runway
79.0 mo
Revenue
$186.7M
Cash Runway vs Catalysts
Tracked catalysts land within the current projected cash runway.
Pipeline (1 candidate)
| Drug | Phase |
|---|---|
| radar | Approved |
Institutional Holdings
Source: SEC Form 13F · as of Mar 2026Institutional holders
254
Total value held
$955.6M
| Holder | Shares | Value |
|---|---|---|
| blackrock, inc. | 19,957,502 | $148.1M |
| vanguard capital management llc | 11,311,646 | $83.9M |
| greenhouse funds lllp | 9,215,903 | $68.4M |
| vanguard portfolio management llc | 7,622,187 | $56.6M |
| first trust advisors lp | 6,162,371 | $45.7M |
| braidwell lp | 5,617,402 | $41.7M |
| state street corp | 5,119,838 | $38.0M |
| d. e. shaw & co., inc. | 4,164,183 | $30.9M |
| schroder investment management group | 3,568,578 | $25.7M |
| nomura asset management international inc. | 3,452,587 | $25.6M |
Showing top 10 of 254 institutional holders of NeoGenomics Inc.. Sign up for the full 13F holder list and quarter-by-quarter ownership history.
Frequently asked questions
How many drug candidates are in NeoGenomics Inc.'s pipeline?
NeoGenomics Inc. (NEO) has 1 pipeline candidate tracked by BioSniper across SEC filings and clinical trial registrations.
What is NeoGenomics Inc.'s lead drug candidate?
NeoGenomics Inc.'s most advanced tracked candidate is radar (Approved) for solid tumor malignancies.
What is NeoGenomics Inc.'s cash runway?
Based on its most recent reported cash balance and quarterly burn rate, NeoGenomics Inc. has approximately 79.0 months of cash runway.
What is NeoGenomics Inc.'s market capitalization?
NeoGenomics Inc.'s market capitalization is approximately $1.4B.
Who is the CEO of NeoGenomics Inc.?
Mr. Anthony P. Zook is the chief executive officer of NeoGenomics Inc. (NEO).
Get the full picture on NeoGenomics Inc.
Deep pipeline analysis, financial trends, AI-powered investment signals, and real-time catalyst alerts.